Cargando…
Rabies virus glycoprotein as a carrier for anthrax protective antigen
Live viral vectors expressing foreign antigens have shown great promise as vaccines against viral diseases. However, safety concerns remain a major problem regarding the use of even highly attenuated viral vectors. Using the rabies virus (RV) envelope protein as a carrier molecule, we show here that...
Autores principales: | Smith, Mary Ellen, Koser, Martin, Xiao, Sa, Siler, Catherine, McGettigan, James P., Calkins, Catherine, Pomerantz, Roger J., Dietzschold, Bernhard, Schnell, Matthias J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576297/ https://www.ncbi.nlm.nih.gov/pubmed/16820183 http://dx.doi.org/10.1016/j.virol.2006.05.010 |
Ejemplares similares
-
Pathogenicity and Immunogenicity of Recombinant Rabies Viruses Expressing the Lagos Bat Virus Matrix and Glycoprotein: Perspectives for a Pan-Lyssavirus Vaccine
por: Kgaladi, Joe, et al.
Publicado: (2017) -
Special Issue: Rabies Symptoms, Diagnosis, Prophylaxis, and Treatment
por: Rupprecht, Charles E., et al.
Publicado: (2017) -
Intravenous Inoculation of a Bat-Associated Rabies Virus Causes Lethal Encephalopathy in Mice through Invasion of the Brain via Neurosecretory Hypothalamic Fibers
por: Preuss, Mirjam A. R., et al.
Publicado: (2009) -
Investigating the Role for IL-21 in Rabies Virus Vaccine-induced Immunity
por: Dorfmeier, Corin L., et al.
Publicado: (2013) -
Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses
por: Plummer, Joseph R., et al.
Publicado: (2019)